Patent Foramen Ovale Closure vs Medical Therapy for Stroke Prevention: Meta-analysis of Randomized Trials and Review of Heterogeneity in Meta-analyses
- 1 October 2014
- journal article
- review article
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 30 (10) , 1216-1224
- https://doi.org/10.1016/j.cjca.2014.05.004
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trialsBMC Cardiovascular Disorders, 2013
- Catheter‐Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN‐3 TrialClinical Cardiology, 2012
- Percutaneous Closure of Patent Foramen OvaleCirculation: Cardiovascular Quality and Outcomes, 2012
- Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke PreventionStroke, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- The Risk of Paradoxical Embolism (RoPE) Study: Developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic strokeTrials, 2011
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and FlutterCanadian Journal of Cardiology, 2011
- Is Patent Foramen Ovale a Modifiable Risk Factor for Stroke Recurrence?Stroke, 2010
- Prevalence of Patent Foramen Ovale in Patients with StrokeNew England Journal of Medicine, 1988
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986